Market Overview

UPDATE: UBS Securities Downgrades Patterson Companies on F2Q14 Preview and Valuation Update

Related PDCO
10 Stocks That Rallied Four Days, Then Sold Off Yesterday
10 Stocks With Lowest Close In Three Weeks

In a report published Wednesday, UBS Securities analyst Steven Valiquette downgraded the rating on Patterson Companies (NASDAQ: PDCO) from Buy to Neutral, but reiterated the $46.00 price target.

In the report, UBS Securities noted, “Based on strong U.S. trends from dental/vet peers, and a much easier dental equip comp, we are comfortable with our $0.49 EPS view vs. Street's $0.48 for PDCO's F2Q14 results to be reported Thurs a.m. (11/21). However, the dental equip comps get much tougher in the back half of FY14, and with pressure on the P&L related to voluntary I/T investments this year, it seems the run-up in the stock (up 26% YTD) has now priced in most of the good news related to U.S. dental trends. With stock now at P/E of 18x on CY14E, and 10x EBITDA, we downgrade to Neutral.”

Patterson Companies closed on Tuesday at $42.88.

Latest Ratings for PDCO

Nov 2016JefferiesMaintainsHold
Oct 2016UBSInitiates Coverage onNeutral
Aug 2016BairdMaintainsNeutral

View More Analyst Ratings for PDCO
View the Latest Analyst Ratings

Posted-In: Steven Valiquette UBS SecuritiesAnalyst Color Downgrades Analyst Ratings


Related Articles (PDCO)

View Comments and Join the Discussion!